blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1353916

EP1353916 - PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.07.2007
Database last updated on 22.05.2024
Most recent event   Tooltip05.10.2007Change - lapse in a contracting state
State(s) deleted from list of lapses: IT
published on 07.11.2007  [2007/45]
Applicant(s)For all designated states
VERTEX PHARMACEUTICALS INCORPORATED
130 Waverley Street
Cambridge, MA 01239-4212 / US
[2006/38]
Former [2003/43]For all designated states
VERTEX PHARMACEUTICALS INCORPORATED
130 Waverley Street
Cambridge, MA 01239-4212 / US
Inventor(s)01 / BEBBINGTON, David
6 Linden Close
Newbury, Berkshire R6141QA / GB
02 / CHARRIER, Jean-Damien, Vertex Pharmaceuticals Inc.
Cottage Wing, Station Rd, Southam
Bishops Itchington, Oxfordshire CV47 2QB / GB
03 / GOLEC, Julian
8 Manor Farm, Chapel Road
Ashbury, Wiltshire SN6 8LS / GB
04 / MILLER, Andrew
Cherry Cottage Chilton Road Upton
Didcot, Oxfordshire OX11 9JL / GB
05 / KNEGTEL, Ronald
3 Bath Court, Bath St
Abingdom, Oxfordshire OX1X1EE / GB
 [2003/43]
Representative(s)Cornish, Kristina Victoria Joy, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2003/43]Cornish, Kristina Victoria Joy, et al
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date01994323.219.12.2001
[2003/43]
WO2001US49401
Priority number, dateUS20000257887P21.12.2000         Original published format: US 257887 P
US20010286949P27.04.2001         Original published format: US 286949 P
[2003/43]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO02057259
Date:25.07.2002
Language:EN
[2002/30]
Type: A2 Application without search report 
No.:EP1353916
Date:22.10.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 25.07.2002 takes the place of the publication of the European patent application.
[2003/43]
Type: B1 Patent specification 
No.:EP1353916
Date:20.09.2006
Language:EN
[2006/38]
Search report(s)International search report - published on:EP24.04.2003
ClassificationIPC:C07D403/12, C07D401/14, A61K31/506, A61P35/00
[2003/43]
CPC:
C07D403/14 (EP,US); C07D401/12 (EP,KR,US); A61P1/00 (EP);
A61P11/06 (EP); A61P13/12 (EP); A61P15/00 (EP);
A61P17/06 (EP); A61P17/14 (EP); A61P19/02 (EP);
A61P19/08 (EP); A61P19/10 (EP); A61P21/00 (EP);
A61P21/02 (EP); A61P21/04 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P3/08 (EP);
A61P3/10 (EP); A61P3/14 (EP); A61P31/12 (EP);
A61P31/18 (EP); A61P31/20 (EP); A61P31/22 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P35/04 (EP);
A61P37/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P5/18 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/08 (EP); A61P9/10 (EP); C07D231/12 (EP,US);
C07D233/56 (EP,US); C07D249/08 (EP,US); C07D401/14 (EP,US);
C07D403/12 (EP,US); C07D405/14 (EP,US); C07D407/14 (EP,US);
C07D409/14 (EP,US); C07D417/14 (EP,US); C07D471/04 (EP,US);
C07D473/16 (EP,US); C07D487/04 (EP,US); C07D491/04 (EP,US);
C07D493/04 (EP,US); C07D495/04 (EP,US); C07D513/04 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/43]
Extension statesAL17.07.2003
LT17.07.2003
LV17.07.2003
MK17.07.2003
RO17.07.2003
SI17.07.2003
TitleGerman:PYRAZOLVERBINDUNGEN ALS PROTEIN- KINASEHEMMER[2006/38]
English:PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS[2003/43]
French:COMPOSES DE PYRAZOLE UTILES EN TANT QU'INHIBITEURS DE PROTEINE KINASE[2003/43]
Former [2003/43]PYRAZOLEVERBINDUNGEN ALS PROTEIN- KINASEHEMMER
Entry into regional phase17.07.2003National basic fee paid 
17.07.2003Designation fee(s) paid 
17.07.2003Examination fee paid 
Examination procedure19.07.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
16.07.2003Amendment by applicant (claims and/or description)
17.07.2003Examination requested  [2003/43]
29.01.2004Despatch of a communication from the examining division (Time limit: M04)
28.05.2004Reply to a communication from the examining division
24.08.2004Despatch of a communication from the examining division (Time limit: M06)
20.06.2005Reply to a communication from the examining division
18.10.2005Communication of intention to grant the patent
11.04.2006Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
06.06.2006Fee for grant paid
06.06.2006Fee for publishing/printing paid
Divisional application(s)EP06011799.1  / EP1702920
EP10184271.4  / EP2264028
Opposition(s)21.06.2007No opposition filed within time limit [2007/35]
Request for further processing for:06.06.2006Request for further processing filed
06.06.2006Full payment received (date of receipt of payment)
Request granted
19.07.2006Decision despatched
20.06.2005Request for further processing filed
21.06.2005Full payment received (date of receipt of payment)
Request granted
04.07.2005Decision despatched
Fees paidRenewal fee
12.12.2003Renewal fee patent year 03
14.12.2004Renewal fee patent year 04
15.12.2005Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2007/45]
Former [2007/35]IT20.09.2006
Cited inInternational search[A]WO0021955  (ZENECA LTD [GB], et al) [A] 1,9* examples 16-20 *;
 [A]WO0039101  (ASTRAZENECA UK LTD [GB], et al) [A] 1,9 * examples 135,160,161 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.